Taking Mental
Health Medication?

Before you begin any mental health medication, put the odds of success in your favor.

– Reduce the frustration of trial-and-error.

– Reduce the risk of adverse side effects.

– Get the assurance you deserve.

Our patented technology helps your healthcare provider select mental health medications that are more likely to work for you—simply by matching the right therapies to your individual brain patterns.

Less Trial and Error:
Here’s How It Works

01

Collect Individualized Data – A simple and painless EEG (electroencephalogram) to characterize your unique brainwaves. An EEG records your electrical brain activity, much like an EKG (electrocardiogram) records heart activity.

02

Compare Your Results – Your results are compared to a large database of other individuals with similar brain patterns. Our solution quickly identifies which medications worked best (or didn’t work at all) for people with brainwaves similar to yours.

03

Improve your odds from Day 1 – We generate a personalized PEER Report for your healthcare provider, to help them select the medications most likely to achieve a positive outcome.

Personalized medicine for mental health? It’s about time.

If you suffer from a mental health condition, you’re not alone. And there’s hope in sight. Our technology can help match you to a medication that has the strongest likelihood for success, based on the world’s largest clinical EEG outcome registry, PEER.

As Seen on:

RECENT MEDIA

MYnd Analytics on CNN – The Lead with Jake Tapper

New brain scan offers hope for PTSD, depression – Fox News

What doctors are saying

"This could revolutionize prescribing practice in terms of helping people get the right treatment sooner."

What patients are saying

"I knew the antidepressants I have been taking weren't helping me much, and the [PEER Report] confirmed that I have been taking the wrong type of medicine for years."

Does PEER really work? Yes.

In pooled results of four Randomized Controlled Studies, medication efficacy tripled in patients on PEER-guided treatment vs. treatment as usual (47% vs. 16%, respectively) for patients with treatment-resistant depression.

MEAN CHANGE FROM BASELINE QIDS

PEER Guided

results

47%

Treatment as Usual

results

16%

Over 50% Improvement in Treatment Efficiency — Patients with PEER-guided therapy reported improvements in outcomes sooner and stayed in treatment longer.

Need some more info?
Let us send you a Free Brochure.

To learn more click below to download our free brochure.

Or give us a call at: (888) 545-2677

REQUEST A BROCHURE